{"id":839567,"date":"2025-04-21T16:53:21","date_gmt":"2025-04-21T20:53:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/"},"modified":"2025-04-21T16:53:21","modified_gmt":"2025-04-21T20:53:21","slug":"regeneron-announces-investor-conference-presentations-14","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/","title":{"rendered":"Regeneron Announces Investor Conference Presentations"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"start\">TARRYTOWN, N.Y., April  21, 2025  (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: <strong>REGN<\/strong>) will webcast management participation as follows:<\/p>\n<ul>\n<li>BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025<\/li>\n<li>2025 RBC Capital Markets Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 20, 2025<\/li>\n<li>Bernstein 41<sup>st<\/sup> Annual Strategic Decisions Conference at 11:00 a.m. ET on Wednesday, May 28, 2025<\/li>\n<li>Goldman Sachs 46<sup>th<\/sup> Annual Global Healthcare Conference at 10:40 a.m. ET on Monday, June 9, 2025<\/li>\n<\/ul>\n<p align=\"start\">The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EKD728J9Ds8xZWfsqHjdZav_MHmy0_fG1uKXfRP_GPOF67nwLZ5OLk4KgkUs70wuku_iTVCe693v41B2NxlQP6vqZwmzIGFaJoDsmFfR8NHm6HCTpwaRMPcmXrtRzTvGEoEXZKlGHy4AfTupl5Kbk1WDUJnjbLfcQloxvo3a7dNQywsF9HXMtKMyb25-kk6TWWPmp-8wXB1_iTxrzjNa5NFeU5a10erPGHYrf6McdEwQ9h7YXLu5o6upK9Lw3ImuEXR61umQ2NJm_sZB63tE4Mkcr5b8PEZtVwFSaIMCr9tysrHGzXCpIChxYgDLpPySJxZkLRRDanthvYNsJQmOaV4NwXp6y_AlldjrADmdphDLndgev0DwG08LI4xfnZ5aJGVpkOm9b8vj4J-_3uTMbXGXIXJj9K5Ojr5t06Naew8_f-SD7oO-ZlcgQizWJBx94FIb61C-KffEQQNO8qyvt2zjhWhRb0I7fwZr-YEWpWG1aH3DZ9MA7IwXnXQQ59RELmXZout6WH3_9D3ay4NdLZSIzncueZuMLCWoseW_RwTTivaCoE-K4-aZ4Z0WkuDrjLTyKfki995pGowzRyk0i18gCbNs4350oginR38RzNuogug7qZ08pm_3lnkzRvDBhkO4tEEtXpvQcbMSKoQPwiCeRdTLrS5AllveI-4QISFk3KqBnPVGg2F5-IzmUc3WMRdemC2PTO_OANYvefxz8bFuuUvjc1wJtDXynF1-5sZKJeWp9RHA8fKUtxMNx2Xa_vFQwau7-F1hhgHeqo0L5YM8hAQs93IdrQ3_8lkcTCUJPUZF_xG5zpeWdN5HVK72euJng23XCtH9IHFNgkAeNOY9GddpldgD4srkdAuAFMzGp_AWpEh9Rke-rOnrHYEYOxAsMsTgSZ27cp-WaJO6Hg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.regeneron.com\/events-and-presentations<\/a>. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days.<\/p>\n<p align=\"start\">\n        <strong>About Regeneron<\/strong><br \/>\n        <br \/> Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to\u00a0repeatedly and consistently translate science\u00a0into medicine has led to numerous approved treatments and\u202fproduct candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious\u00a0diseases, and rare diseases.<\/p>\n<p align=\"start\">Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as <em>VelociSuite<\/em><sup><em>\u00ae<\/em><\/sup>, which produces optimized fully human antibodies and new classes of bispecific antibodies.\u202fWe are shaping the next frontier of medicine with data-powered insights from the\u202fRegeneron Genetics Center<sup>\u00ae<\/sup>\u202fand pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.<\/p>\n<p align=\"start\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R1S1S8BPRU2PhyvoFXHtoAvz0TNIjH-b32lCaXn0EgFI_tTk4gKRI0_zynjFN8sDYym1AyO7yEnIyhMxMyefNIRu3x39mSundSR2cBxkPBM=\" rel=\"nofollow\" target=\"_blank\"><u>www.Regeneron.com<\/u><\/a> or follow Regeneron on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nlWwVxr6-K3J6ZaLCJgeSGvQQvRkHT1HAUHRQLBzUTMXWXKgPoQvNWBgvsCVwOgFABJ41VSwHhAbbClQEOk0lq3hWbJHKVtYzfwEwgxiyAKeawtnK3lyh5F-RIyou_7EW-qRu2C_51tJlreQAv5avwc5hYfljR8AsbSpZtwOhvc=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3u_cezkKQ9zh4fAqzb7QopuhM_cR6tyVW-b7McXc4HMv7rZ_hQRsZZiBdwoCG9SQTOKu2d3XSTqWhpNu7nfSNCKCMV-zQwbuMVgT_h84QWBwZVb4NYChlwx9bfgEjs6obWRgDCC2e9Mnmzuq2bFAQpFH8yj1rq3JmzH97vnPz8DwyCz6NEnmeoD1HOozn4CBbffOHs7ylKuCjhSG2gHxKGV2a50-7ZWyLY4OsDpC6nfcvlSqtXW4h0ZyqZDEtH1v\" rel=\"nofollow\" target=\"_blank\"><u>Instagram<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CM4YDe2vZxmaCAeFm5imaX8JJgofnvY_ml1XlK_MIyUuFWgnrQ6xIBCrzvrJAKOcbFJMpt9WNqtH8k7IJJYOaHmg__U40oUH7Q8pcOf_l3YeYzhv4ayrQCiTN30U5OIUAE8JLNlDdtLoZyxh4pl5kTH4L6DbJ-GElnaCC3nq0HW0u-BiTiwK5j0oy5PZZPpZRR4FEDWETf5DaHkbTJg6qM22nU2KWZYmjIFKro6iMO_vR6-imVOQscXoAshLEG4L\" rel=\"nofollow\" target=\"_blank\"><u>Facebook<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S2Luh_cjZ5zbzverSv7vAYVZF4kifSNp0kGwgmeDiY-59RxelPLvGLGLMV4VT2rQlCZceBouH3vfOUdlUspDzVa9tRkBIvarRfxhCDU7Rxfkj2wXOcjXQIXI75DsDwWuM60Uir4oYtw1Jt-XOviyVct1hr3z_HKmAr67IspOqOcq90rq0yrtDcY9B7xTESBUi9qtCnZtVVlmXTE_WvRmOQ==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<p align=\"start\">\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/> Investor Relations <br \/> Ryan Crowe <br \/> 914.847.8790 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8F2_na1oGwWWQFDF2yn1q39mHLbYaMFkq9AnewYVzvrQcHBbFaEnczQhuP17OJAxQ9KLK4q_LFv5dnoxHmiHUve9MC9RyEuQgcIelmEUD7S_Emq26e04CjEwfAdbjeWr\" rel=\"nofollow\" target=\"_blank\"><u>ryan.crowe@regeneron.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjRlYTE2ZTUtMDllOS00ZDFjLWEzOTktY2VmNzlhYTE5MzUwLTEwMTc4MjMtMjAyNS0wNC0yMS1lbg==\/tiny\/Regeneron-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025 2025 RBC Capital Markets Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 20, 2025 Bernstein 41st Annual Strategic Decisions Conference at 11:00 a.m. ET on Wednesday, May 28, 2025 Goldman Sachs 46th Annual Global Healthcare Conference at 10:40 a.m. ET on Monday, June 9, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron Announces Investor Conference Presentations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839567","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron Announces Investor Conference Presentations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025 2025 RBC Capital Markets Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 20, 2025 Bernstein 41st Annual Strategic Decisions Conference at 11:00 a.m. ET on Wednesday, May 28, 2025 Goldman Sachs 46th Annual Global Healthcare Conference at 10:40 a.m. ET on Monday, June 9, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron &hellip; Continue reading &quot;Regeneron Announces Investor Conference Presentations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-21T20:53:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron Announces Investor Conference Presentations\",\"datePublished\":\"2025-04-21T20:53:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/\",\"name\":\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\",\"datePublished\":\"2025-04-21T20:53:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-14\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron Announces Investor Conference Presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","og_description":"TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025 2025 RBC Capital Markets Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 20, 2025 Bernstein 41st Annual Strategic Decisions Conference at 11:00 a.m. ET on Wednesday, May 28, 2025 Goldman Sachs 46th Annual Global Healthcare Conference at 10:40 a.m. ET on Monday, June 9, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron &hellip; Continue reading \"Regeneron Announces Investor Conference Presentations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-21T20:53:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron Announces Investor Conference Presentations","datePublished":"2025-04-21T20:53:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/","name":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=","datePublished":"2025-04-21T20:53:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTYxMyM2ODk1ODQzIzIwMDYyNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-14\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron Announces Investor Conference Presentations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839567"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839567\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}